Celularity Inc expected to post a loss of 25 cents a share - Earnings Preview

Celularity

10/03/2023 21:36

* Celularity Inc  CELU.OQ   CELU.O  is expected to show a
rise in
quarterly revenue when it reports  results on March 13
(estimated). 
    * The Florham Park New Jersey-based  company is expected to
report
 a 12.8% increase in revenue to $5.477 million from $4.86
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Celularity Inc is
for a
loss of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Celularity
Inc is
$6​, above​ its last closing price of $0.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.28       -0.26      0.03      Beat    111.5
 Jun. 30 2022  -0.26       -0.26      0.32      Beat    222.1
 Mar. 31 2022  -0.26       -0.26      -0.48     Missed  -82.3​
 Dec. 31 2021  -0.34       -0.31      -0.03     Beat    90.3
 ​​Sep.        -0.34       -0.34      0.40      Beat    215.9
 30 2021                                                
 Jun. 30 2021  -0.16       -0.16      -2.69     Missed  -1,581
                                                        .2​
 Mar. 31 2021  -0.14       -0.14      2.48      Beat    1,871.
                                                        4
 This summary was machine generated March 10 at 21:36 GMT.  All
figures in US dollars  unless otherwise stated